Search research articles
Contact Us
Filters
Showing results (191-200 of 234) with videos related to
Page
of 24
Sort By:
British Journal of Haematology
|
October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia
Zaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2023
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial
Sikander Ailawadhi, Zi Chen, Bo Huang, et al.
American Journal of Hematology
|
February 25, 2026
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone
Ricardo D Parrondo, Ricardo C B de Menezes, Hanna Sledge, et al.
Blood Cancer Journal
|
July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 29, 2025
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma
Matthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, et al.
Blood Cancer Journal
|
December 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
Kenneth J C Lim, Melinda Tan, Ricardo Parrondo, et al.
Transplantation and Cellular Therapy
|
November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation
Surbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Blood Cancer Journal
|
September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Paul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Advances
|
October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell Therapy
Melinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 234) with videos related to
Sort By:
Page
of 24
British Journal of Haematology
|
October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia
Zaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2023
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial
Sikander Ailawadhi, Zi Chen, Bo Huang, et al.
American Journal of Hematology
|
February 25, 2026
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone
Ricardo D Parrondo, Ricardo C B de Menezes, Hanna Sledge, et al.
Blood Cancer Journal
|
July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 29, 2025
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma
Matthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, et al.
Blood Cancer Journal
|
December 31, 2025
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
Kenneth J C Lim, Melinda Tan, Ricardo Parrondo, et al.
Transplantation and Cellular Therapy
|
November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation
Surbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Blood Cancer Journal
|
September 1, 2022
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
Paul J Hampel, Kari G Rabe, Timothy G Call, et al.
Blood Advances
|
October 15, 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell Therapy
Melinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, et al.
Page
of 24